| Lizenz: Creative Commons Namensnennung 4.0 International (479kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-367909
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.36790
Zusammenfassung
Programmed death ligand 1 (PD-L1) expression is an efficient strategy of tumor cells to escape immunological eradiation. However, only little is known about the factors that affect the cellular expression levels. Here we assessed the PD-L1 expression on different breast cancer cell lines under standard in vitro culture conditions and as a function of Epirubicin or Paclitaxel treatment. Moreover, ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik